These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

879 related items for PubMed ID: 18804736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Benefits of the implantable cardioverter-defibrillator.
    Epstein AE.
    J Am Coll Cardiol; 2008 Sep 30; 52(14):1122-7. PubMed ID: 18804737
    [Abstract] [Full Text] [Related]

  • 3. Sudden death prevention with implantable devices.
    Passman R, Kadish A.
    Circulation; 2007 Jul 31; 116(5):561-71. PubMed ID: 17664385
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):1993-2000. PubMed ID: 19926003
    [Abstract] [Full Text] [Related]

  • 7. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M.
    Expert Rev Cardiovasc Ther; 2009 Feb 24; 7(2):181-95. PubMed ID: 19210214
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sudden cardiac death: opportunities for prevention.
    Morgan JM, Cowan JC, Camm AJ, McComb JM.
    Heart; 2006 Jun 24; 92(6):721-3. PubMed ID: 16159972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):112-21. PubMed ID: 16814657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK, DiMarco JP.
    Cardiol Clin; 2008 Aug 04; 26(3):433-9, vii. PubMed ID: 18538189
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.